Aurobindo Pharma Ltd — Atorvastatin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Atorvastatin · $33.2M export value · DGFT Verified
Aurobindo Pharma Ltd is the #7 Indian exporter of Atorvastatin with $33.2M in export value and 879 verified shipments. Aurobindo Pharma Ltd holds a 4.4% market share in Atorvastatin exports across 11 countries.
Aurobindo Pharma Ltd — Atorvastatin Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Atorvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $8.0M | 963 | 51.9% |
| FRANCE | $4.1M | 285 | 26.7% |
| CANADA | $1.8M | 69 | 11.6% |
| UNITED KINGDOM | $972.0K | 74 | 6.3% |
| OMAN | $243.2K | 24 | 1.6% |
| IRAQ | $95.5K | 12 | 0.6% |
| MEXICO | $77.2K | 2 | 0.5% |
| NETHERLANDS | $76.2K | 13 | 0.5% |
| PORTUGAL | $11.6K | 1 | 0.1% |
| TANZANIA | $11.2K | 3 | 0.1% |
Aurobindo Pharma Ltd exports Atorvastatin to 12 countries. The largest destination is MALTA accounting for 51.9% of Aurobindo Pharma Ltd's Atorvastatin shipments, followed by FRANCE (26.7%) and CANADA (11.6%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atorvastatin from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $5.7M | 640 |
| ARROW GENERIQUES, | FRANCE | $2.8M | 195 |
| AURO PHARMA INC, | CANADA | $1.1M | 35 |
| ARROW GENERIQUES | FRANCE | $999.1K | 65 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $771.7K | 68 |
| APL SWIFT SERVICES (MALTA) LIMITED | MALTA | $597.0K | 55 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $454.9K | 101 |
| AURO PHARMA INC | CANADA | $408.7K | 21 |
| MILPHARM LIMITED | UNITED KINGDOM | $246.9K | 14 |
| MILPHARM LIMITED ALLOGA UKAMBER PARK | UNITED KINGDOM | $211.0K | 14 |
Aurobindo Pharma Ltd supplies Atorvastatin to 41 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by ARROW GENERIQUES, (FRANCE) and AURO PHARMA INC, (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atorvastatin Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $313.7M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. Aurobindo Pharma Ltd contributes $33.2M to this total, accounting for 4.4% of India's Atorvastatin exports. Aurobindo Pharma Ltd ships Atorvastatin to 12 countries through 41 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Atorvastatin Exports?
Aurobindo Pharma Ltd's average Atorvastatin shipment value is $37.7K per consignment, based on 879 shipments totaling $33.2M. The largest destination is MALTA (51.9% of Aurobindo Pharma Ltd's Atorvastatin exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Atorvastatin Exporters?
Aurobindo Pharma Ltd ranks #7 among 477 Indian Atorvastatin exporters with a 4.4% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($83.7M), AUROBINDO PHARMA LTD ($33.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($32.8M). Aurobindo Pharma Ltd processed 879 shipments to 11 destination countries.
What Atorvastatin Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN 20 MG TABLETS(Atorvastatina | $656.3K | 23 |
| ATORVASTATIN 40 MG TABLETS(Atorvastatina | $589.1K | 25 |
| ATORVASTATIN 20 MG TABLETS(Apo-Atorva,20 | $409.2K | 12 |
| ATORVASTATIN 10 MG TABLETS(Atorvastatina | $358.2K | 20 |
| ATORVASTATIN 40 MG TABLETS(AURO-ATORVAST | $320.0K | 12 |
| ATORVASTATIN 80 MG TABLETS(Atorvastatina | $310.6K | 11 |
| ATORVASTATIN 80 MG TABLETS (ATORVASTATIN | $310.1K | 11 |
| ATORVASTATIN 40 MG TABLETS(ATORVASTATINE | $297.7K | 15 |
| ATORVASTATIN 40 MG TABLETSAtorvastatin 40 mg Film coated tablets28'S | $259.1K | 9 |
| ATORVASTATIN 10 MG TABLETS (ATORVASTATIN | $210.2K | 9 |
Aurobindo Pharma Ltd exports 706 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN 20 MG TABLETS(Atorvastatina with 23 shipments worth $656.3K.
Regulatory Requirements: Exporting Atorvastatin to Key Markets
What Aurobindo Pharma Ltd must comply with to export Atorvastatin to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Atorvastatin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | MSN LABORATORIES PRIVATE LIMITED | $83.7M | 3,224 | 20 | $26.0K |
| 7 | AUROBINDO PHARMA LTD ★ | $33.2M | 879 | 11 | $37.7K |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $32.8M | 1,299 | 18 | $25.3K |
| 9 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $24.0M | 664 | 1 | $36.1K |
Aurobindo Pharma Ltd ranks #7 among 477 Indian Atorvastatin exporters. Average shipment value of $37.7K compared to the market average of $657.7K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Atorvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 2,042 | 13.6% |
| HYDERABAD ICD (INSNF6) | 1,131 | 7.5% |
| NHAVA SHEVA SEA (INNSA1) | 842 | 5.6% |
| SAHAR AIR | 839 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 779 | 5.2% |
| DELHI AIR | 613 | 4.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 581 | 3.9% |
| HYDERABAD AIR | 554 | 3.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,448 individual customs records matching Aurobindo Pharma Ltd exporting Atorvastatin, covering 706 formulations to 12 countries via 41 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Atorvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Atorvastatin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current shipment-level data, contact TransData Nexus.